Industry Reports
Novartis successfully completes acquisition of AveXis, Inc.
Novartis AG announced that it has completed the acquisition of AveXis, Inc. through the consummation of a merger of its indirect wholly-owned subsidiary, Novartis AM Merger Corp, with and into AveXis without a vote of the AveXis stockholders in...
Industry Reports
Lilly to buy cancer drug developer AurKa Pharma
Eli Lilly and Company announced an agreement to acquire AurKa Pharma, Inc., a company established by TVM Capital Life Science to develop oncology compound AK-01, an Aurora kinase A inhibitor that was originally discovered at Lilly. ...
Industry Reports
Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials
Leading Asia Pacific CRO Novotech commended the Turnbull Government's Federal Budget decision to exclude clinical trials activity from a A$4m cap on cash refunds, or any lifetime cap on refunds. Novotech CEO Dr John Moller said...
Industry Reports
TraceLink Achieves 69% Overall Revenue Growth in Q1 2018, Including 270% Revenue Growth in EMEA
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, announced financial and company results for the first quarter of 2018. ...
Industry Reports
Ardena acquires Syntagon and strengthens API offering
Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients. The acquisition, which is the CDMO’s first outside the Benelux region, expands its drug...
Industry Reports
Sterling Pharma Solutions experiences record US growth
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has more than doubled its sales in the US over the last two years. The increase in sales forms part of the company’s growth strategy, which...
Industry Reports
MIMETAS Secures 20 Million Dollar Series B Financing
MIMETAS, leader in organ-on-a-chip products and tissue models, has secured 20.5 million USD in financing from an international syndicate from Asia and Europe. MIMETAS will use the proceeds of this Series B financing round to expand...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
